The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement

This study is currently recruiting participants.

Verified August 2011 by University Hospital, Strasbourg, France

First Received on December 12, 2007. Last Updated on August 22, 2011 History of Changes

Sponsor:	University Hospital, Strasbourg, France
Information provided by (Responsible Party):	University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:	NCT00576134

Purpose

Supplement pharyngolaryngeal deficient functions by insertion of a prosthesis with valves in order to allow tracheotomy closing (when applicable) and / or to allow restoration of god swallowing capacity. The secondary objective is to study the concept of a special valves system for the development of an artificial larynx

Condition	Intervention	Phase
Swallowing Disorders Dysphagia Laryngeal Neoplasms	Device: Implantation of intralaryngeal prosthesis with a new double valve system, allowing tracheotomy closing	Phase I

Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Artificial Larynx : Intralaryngeal Prosthesis With Valve in Major Swallowing Troubles

Resource links provided by NLM:

MedlinePlus related topics: Cancer Swallowing Disorders

U.S. FDA Resources

Further study details as provided by University Hospital, Strasbourg, France:

Primary Outcome Measures:

Respiratory evaluation [ Time Frame: Day : 1, 2, 3, 4, 5, 15 - month :1, 3, 6, 12, 18, 24, 30, 36 ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:

Nasofibroscopy [ Time Frame: Day : 15 - month : 1, 3, 6, 12, 18, 24, 30, 36 ] [ Designated as safety issue: No ]

Estimated Enrollment:	10
Study Start Date:	February 2008
Estimated Study Completion Date:	February 2013
Estimated Primary Completion Date:	February 2013 (Final data collection date for primary outcome measure)

Intervention Details:

An artificial Larynx composed of a tracheobronxane ® Dumon ST prosthesis and a valves system will be implant under general anesthesia by endoscopy. The 3 first patients will be patients with tracheotomy, in order to allow breathing through this tracheotomy in case of valves dysfunction.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria:

Age more than 18
Swallowing troubles

Exclusion criteria:

Pregnant women
Contraindications to general anesthesia

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00576134

Contacts

Contact: Christian DEBRY, MD

33.3.88.12.76.45

christian.debry@chru-strasbourg.fr

Locations

France
Service d'ORL et de Chirurgie Cervico-Faciale, Hôpital de Hautepierre, 1 avenue Molière	Recruiting
Strasbourg, France, 67098
Contact: Christian DEBRY, MD 33.3.88.12.76.45 christian.debry@chru-strasbourg.fr
Principal Investigator: Christian DEBRY, MD
Sub-Investigator: Patrick HEMAR, MD
Sub-Investigator: Philippe SCHULTZ, MD
Sub-Investigator: Anne CHARPIOT, MD

Sponsors and Collaborators

University Hospital, Strasbourg, France

Investigators

Principal Investigator:

Christian DEBRY, MD

Hôpitaux Universitaires de Strasbourg

More Information

No publications provided

Responsible Party:	University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:	NCT00576134 History of Changes
Other Study ID Numbers:	3866
Study First Received:	December 12, 2007
Last Updated:	August 22, 2011
Health Authority:	France: Afssaps - French Health Products Safety Agency

Keywords provided by University Hospital, Strasbourg, France:

Larynx, tracheotomy, titanium beads

Additional relevant MeSH terms:

Neoplasms
Deglutition Disorders
Laryngeal Neoplasms
Esophageal Diseases
Gastrointestinal Diseases
Digestive System Diseases
Pharyngeal Diseases

Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Head and Neck Neoplasms
Neoplasms by Site
Laryngeal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms

ClinicalTrials.gov processed this record on February 12, 2012